Author(s):
Sameera Akhtar, Sufhia Akhter, Shoket Ali, Imran Bashir
Email(s):
sameerazargar@gmail.com
DOI:
10.52711/0974-360X.2024.00200 
Address:
Sameera Akhtar1*, Sufhia Akhter2, Shoket Ali3, Imran Bashir4
1Demonstrator, Department of Microbiology, GMC Doda, J&K India.
2Assistant Professor, Department of Microbiology, GMC Doda, J&K India.
3Consultant, Department of Medicine, Raja Hospital Nawanshahr, Punjab.
4Veterinary Assistant Surgeon, Department of Sheep Husbandry, Kashmir.
*Corresponding Author
Published In:
Volume - 17,
Issue - 3,
Year - 2024
ABSTRACT:
A new corona virus pandemic (COVID-19) has caused 7,010,568 deaths worldwide. The three stages of the Covid-19 disease course include the asymptomatic stage, upper respiratory tract infection, and lower respiratory tract infection/ARDS. Materials and methods: We examined the dynamical profile of SARS CoV-2 in 100 COVID-19-infected hospitalised patients from Jammu and Kashmir's Chenab valley (Doda, Bhaderwah, and Kishtwar). Patients' throat and nasal swab samples were taken at various times following the onset of symptoms. RT-PCR test with a COVID-19 nucleic acid detection was used to find SARS-CoV-2. The real-time RT-PCR assay examined two target genes: nucleocapsid protein (N) and open reading frame 1ab (ORF1ab). AIM: To assess the SARS-CoV2 positive detection rate using real-time polymerase chain reaction (RT-PCR). Results: At one week after the onset of symptoms, the PCR positivity rate was 100%; it then gradually decreased until it reached 100% negative results at six weeks following the onset of symptoms. Up to 6 weeks following the start of symptoms, viral shedding took place. For senior individuals, an extended monitoring period is required. Conclusion: This study discovered that individuals with extended viral nucleic acid conversion were typically older and had more co-morbid conditions, such as diabetes and hypertension.
Cite this article:
Sameera Akhtar, Sufhia Akhter, Shoket Ali, Imran Bashir. Profile of RT-PCR for SARS-CoV-2: A Preliminary Study from COVID-19 patients in Government Medical College and Hospital, Doda, Jammu and Kashmir. Research Journal of Pharmacy and Technology. 2024; 17(3):1277-1. doi: 10.52711/0974-360X.2024.00200
Cite(Electronic):
Sameera Akhtar, Sufhia Akhter, Shoket Ali, Imran Bashir. Profile of RT-PCR for SARS-CoV-2: A Preliminary Study from COVID-19 patients in Government Medical College and Hospital, Doda, Jammu and Kashmir. Research Journal of Pharmacy and Technology. 2024; 17(3):1277-1. doi: 10.52711/0974-360X.2024.00200 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-3-51
REFERENCES:
1. Priyanka K. Shinde, Dattaprasad N. Vikhe, Ravindra S. Jadhav, Ganesh S. Shinde. Pharmacological Potential of Natural Herbs against Covid-19: A Review. Research Journal of Science and Technology. 2021; 13(4): 269-4. doi: 10.52711/2349-2988.2021.00043
2. Kishor R, Ramhari B. Introduction to Covid-19. Research J. Science and Tech. 2020; 12(4): 338-345. doi: 10.5958/2349-2988.2020.00051.0
3. World Health Organization. COVID-19 weekly epidemiological update, edition 79, 15 February 2022.
4. National Health Mission Jammu and Kashmir. J&K COVID Statistics as on 07-Jun-2022. www.jknhm.com
5. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England journal of medicine. 2020; 382(12): 1177-9. doi:10.1056/NEJMc2001737.
6. Pan Y, Zhang D, Yang P, Poon LL, Wang Q. Viral load of SARS-CoV-2 in clinical samples. The Lancet infectious diseases. 2020; 20(4): 411-2. doi.10.1016/ S1473-3099(20)30113–4.
7. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020; 323(18): 1843-4. doi: 10.1001/jama.2020.3786.
8. Sarkar N, Mandal B, Paul S. Activity, Effect on Human and Salvation from effect of COVID-19. Asian Journal of Management. 2021; 12(2): 228-4. doi: 10.52711/2321-5763.2021.00035 Parasher A. Postgrad Med J 2021;97:312–320.
9. Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad Med J. 2021; 97(1147): 312-320. doi: 10.1136/postgradmedj-2020-138577. Epub 2020 Sep 25. PMID: 32978337; PMCID: PMC10017004.
10. Lauer SA, Grantz KH. Qifang Bi, Forrest K Jones, Qulu Zheng, Hannah R Meredith, Andrew S Azman, Nicholas G Reich, and Justin Lessler. The incubation period of coronavirus disease 2019 (covid-19) from publicly reported confirmed cases: estimation and application. Annals of Internal Medicine. 2020; 172(9): 577-82. https://doi.org/10.7326/M20-0504
11. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet. 2020; 395(10223): 496-496. https://doi.org/10.1016/S0140-6736(20)30183-5
12. Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID‐19 patients. The Laryngoscope. 2020; 130(7): 1787-. https://doi.org/10.1002/lary.28692
13. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology. 2020; 94(7): e00127-20. https://doi.org/10.1128/JVI.00127-20
14. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell. 2020; 181(2): 271-80. https://doi.org/10.1016/j.cell.2020.02.052
15. Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, Pickles RJ. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. Journal of virology. 2005; 79(24): 15511-24. https://doi.org/10.1128/JVI.79.24.15511-15524.2005
16. Tang NL, Chan PK, Wong CK, To KF, Wu AK, Sung YM, Hui DS, Sung JJ, Lam CW. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clinical Chemistry. 2005; 51(12): 2333-40. https://doi.org/10.1373/clinchem.2005.054460
17. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Statpearls [internet]. 2022 Feb 5. PMID: 32150360
18. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420–2. https://doi.org/10.1016/S2213-2600(20)30076-X
19. Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. The American journal of pathology. 2007; 170(4): 1136-47. https://doi.org/10.2353/ajpath.2007.061088
20. CDC. (2020). 2019 Novel Coronavirus (2019-nCoV), Wuhan, China. https://www.cdc.gov/coronavirus/novel-coronavirus-2019.html
21. Lin L, Li TS. interpretation of" guidelines for the diagnosis and treatment of novel coronavirus (2019-ncov) infection by the national health commission (trial version 5)". Zhonghua yi xue za zhi. 2020; 100: E001-. DOI: 10.3760/cma.j.issn.0376-2491.2020.0001
22. Ramesh D. Ingole, Avinash B. Thalkari, Pawan N. Karwa. Is Prevaccination the reason for less morbidity and mortality for COVID-19 in India: An Epidemiological study. Research J. Science and Tech. 2020; 12(4): 285-288. doi: 10.5958/2349-2988.2020.00038.8
23. Balai MK. UK Variant COVID-19. Asian Journal of Nursing Education and Research. 2021; 11(4): 601-4. doi: 10.52711/2349-2996.2021.00140
24. Alaraj M. Pharmacological repurposed agents for COVID-19. Research Journal of Pharmacy and Technology. 2022; 15(1): 441-6. doi: 10.52711/0974-360X.2022.00073
25. Vaishnavi. K. Patil, Azam. Z. Shaikh. Corona (Covid - 19). Asian J. Pharm. Res. 2020; 10(4): 275-285. doi: 10.5958/2231-5691.2020.00048.9
26. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www. who. int/csr/sars/country/table2004_04_21/en/index. html. 2003 Sep.
27. Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. The Journal of Infectious Diseases. 2020; 221(11): 1757-61. doi: 0.1093/infdis/jiaa077
28. Chan JF, Yuan S, Kok K, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. Published online January 24, 2020. doi: 10.1016/ S0140-6736(20)30154–9.
29. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. The Lancet. 2003; 361(9371): 1767-72. https://doi.org/10.1016/S0140-6736(03)13412-5
30. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020; 382(18): 1708-20. doi: 10.1056/ NEJMoa2002032.
31. Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, Xu H. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. 2020; 323(15): 1502-3. doi:10.1001/jama.2020.2783
32. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239-42. doi:10.1001/jama.2020.2648
33. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KS, Lau EH, Wong JY, Xing X. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020. doi: 10.1056/NEJMoa2001316.
34. McCloskey B, Heymann DL. SARS to novel coronavirus–old lessons and new lessons. Epidemiology and Infection. 2020; 148. . https://doi.org/10.1017/ S0950268820000254